Evidence map›Paper›PMID 40517399›Full record

ArticlePlant biotechnology journal2025

Molecular pharming in maize endosperm: A proof of concept with recombinant SARS-CoV-2 antigen production.

Yuxin Tai, Shujun Meng, Yiteng Zhang, Jianfeng Weng, Xinhai Li, Qingyu Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plant biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuxin Tai *State Key Laboratory of Efficient Utilization of Arable Land in China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, China.
Shujun Meng *State Key Laboratory of Efficient Utilization of Arable Land in China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, China.
Yiteng Zhang *Institute of Crop Cultivation and Farming, Heilongjiang Academy of Agricultural Sciences, Heilongjiang Academy of Agricultural Sciences, Harbin, China.
Jianfeng WengInstitute of Crop Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.ORCID https://orcid.org/0000-0002-4798-6351
Xinhai LiInstitute of Crop Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Qingyu WuState Key Laboratory of Efficient Utilization of Arable Land in China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, China.ORCID https://orcid.org/0000-0003-3064-2445

Funding

Agricultural Science and Technology Innovation Program CAAS-CSAL-202301Fundamental Research Funds for Central Non-profit Scientific Institution 1610132023007Fundamental Research Funds for Central Non-profit Scientific Institution Y2024XK03Fundamental Research Funds for Central Non-profit Scientific Institution Y2025CG05Fundamental Research Funds for Central Non-profit Scientific Institution Y2025YC70Nanfan Special Project (CAAS) YBXM2545National Natural Science Foundation of China 32171925National Natural Science Foundation of China 32401742
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

maizemolecular pharmingRBDSARS‐CoV‐2Spike

Identifiers

PMID40517399
PMCPMC12392926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.